@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-KR314PF5-R mesh:allowableQualifier jvr:-R0ZCQ8X6-J, jvr:-HQRFT0C6-B, jvr:-Q3979798-W, jvr:-TJHVZCRZ-0, jvr:-NHL3D2X0-S, jvr:-R3QWLHRG-V, jvr:-L6C0XPHT-4, jvr:-XV06LPML-W, jvr:-THHNVC7V-3, jvr:-H7K65Q8S-Z, jvr:-CB30NGKB-3, jvr:-D0F21513-5, jvr:-M63HSDM7-1, jvr:-FWD2BGQ0-9, jvr:-W6SQV79N-S, jvr:-BT300B3G-Q, jvr:-NB0XHT3S-N, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-NFTHND7Q-8, jvr:-T9HQD7ST-J, jvr:-S0CS1X5R-5, jvr:-WK5F724J-1, jvr:-G4R176S9-J, jvr:-NKM836P1-M ; skos:hiddenLabel "BM 210955"@en, "Ibandronate"@fr, "Ibandronate"@en, "Ibandronic Acid, Sodium Salt, Monohydrate"@en, "RPR-102289A"@fr, "RPR-102289A"@en, "Bonviva"@en, "1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate"@en, "(1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate"@en, "Ibandronate de sodium"@fr, "Ibandronate Sodium Anhydrous"@en, "Ibandronate Sodium"@en, "Bondronat"@en, "BM-210955"@fr, "BM-210955"@en, "BM-21.0955"@en, "Boniva"@en, "BM 21.0955"@en, "RPR 102289A"@en, "Ibandronate sodique"@fr ; skos:inScheme jvr: ; mesh:pharmacologicalAction jvr:-BBJDHV4W-1 ; a mesh:Descriptor, skos:Concept ; skos:altLabel "Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-"@en, "Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-"@fr, "114084-78-5 (Ibandronic Acid)"@fr, "114084-78-5 (Ibandronic Acid)"@en, "23Y0B94E49"@fr, "23Y0B94E49"@en, "J12U072QL0"@fr, "J12U072QL0"@en, "UMD7G2653W"@en, "UMD7G2653W"@fr ; owl:sameAs ; dc:modified "2018-07-03"^^xsd:date ; skos:prefLabel "Acide ibandronique"@fr, "Ibandronic Acid"@en ; skos:broader jvr:-NBRNK6HL-M ; dc:established "2019-01-01"^^xsd:date ; dc:created "2018-07-09"^^xsd:date ; skos:definition "Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS."@en . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NBRNK6HL-M skos:prefLabel "Diphosphonates"@fr, "Diphosphonates"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-KR314PF5-R . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-BBJDHV4W-1 skos:prefLabel "Bone Density Conservation Agents"@en, "Agents de maintien de la densité osseuse"@fr ; a mesh:Descriptor, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .